Century Therapeutics, INC. (IPSC) — 8-K Filings

All 8-K filings from Century Therapeutics, INC.. Browse 23 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (23)

8-K Filing — Dec 29, 2025
Century Therapeutics Files 8-K — Dec 12, 2025 Risk: low
Century Therapeutics, Inc. filed an 8-K on December 12, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not co
8-K Filing — Dec 9, 2025
Century Therapeutics Faces Delisting Notice — Aug 29, 2025 Risk: high
Century Therapeutics, Inc. filed an 8-K on August 29, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of Aug
Century Therapeutics (IPSC) Files 8-K — Aug 14, 2025 Risk: low
On August 13, 2025, Century Therapeutics, Inc. (IPSC) filed an 8-K report. The filing indicates the company's principal executive offices are located at 25 Nort
Century Therapeutics Reports Exit Costs & Officer Changes — Jul 7, 2025 Risk: medium
Century Therapeutics, Inc. filed an 8-K on July 7, 2025, reporting on cost-associated exit or disposal activities and changes in directors and officers. The fil
Century Therapeutics Files 8-K on Shareholder Vote Matters — Jun 16, 2025 Risk: low
Century Therapeutics, Inc. filed an 8-K on June 16, 2025, reporting on matters submitted to a vote of security holders as of June 12, 2025. The filing details t
Century Therapeutics Files 8-K on Financials — May 15, 2025 Risk: low
Century Therapeutics, Inc. filed an 8-K on May 15, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD
8-K Filing — Mar 19, 2025
Century Therapeutics Faces Delisting Concerns — Feb 28, 2025 Risk: high
Century Therapeutics, Inc. filed an 8-K on February 28, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with t
Century Therapeutics Files 8-K on Financials — Jan 13, 2025 Risk: low
Century Therapeutics, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also includes disclosure
Century Therapeutics Terminates Material Agreement — Dec 13, 2024 Risk: medium
On December 12, 2024, Century Therapeutics, Inc. reported the termination of a material definitive agreement. The filing does not specify the counterparty or th
Century Therapeutics Files 8-K — Nov 5, 2024 Risk: low
On November 5, 2024, Century Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's financial condition and other events, along wit
Century Therapeutics Appoints New CMO, Director — Sep 26, 2024 Risk: medium
Century Therapeutics, Inc. announced on September 26, 2024, the appointment of Dr. Lishan Chen as Chief Medical Officer and the election of Dr. David R. Boulwar
Century Therapeutics Files 8-K on Financials — Aug 8, 2024 Risk: low
On August 8, 2024, Century Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, al
Century Therapeutics Files 8-K — Jul 8, 2024 Risk: low
On July 8, 2024, Century Therapeutics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific
Century Therapeutics Reports on Shareholder Vote Matters — Jun 24, 2024 Risk: low
Century Therapeutics, Inc. filed an 8-K on June 24, 2024, reporting on matters submitted to a vote of security holders as of June 20, 2024. The filing does not
EQT AB to Acquire Century Therapeutics for $1.5B — Jun 3, 2024 Risk: medium
Century Therapeutics, Inc. announced on June 3, 2024, that it has entered into a definitive agreement to be acquired by a subsidiary of EQT AB. The transaction
Century Therapeutics Files 8-K on Financials — May 9, 2024 Risk: low
Century Therapeutics, Inc. filed an 8-K on May 9, 2024, reporting on its results of operations and financial condition. The filing includes financial statements
Century Therapeutics Files 8-K — Apr 11, 2024 Risk: low
On April 11, 2024, Century Therapeutics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material ev
EQT AB to Acquire Century Therapeutics for $1.5B — Apr 9, 2024 Risk: medium
Century Therapeutics, Inc. announced on April 8, 2024, that it has entered into a definitive agreement to be acquired by a subsidiary of EQT AB. The transaction
Century Therapeutics Files 8-K on Financials — Mar 14, 2024 Risk: low
Century Therapeutics, Inc. filed an 8-K on March 14, 2024, reporting on its results of operations and financial condition. The filing also includes Regulation F
Century Therapeutics Files 8-K on Officer/Director Changes, Comp — Jan 19, 2024
Century Therapeutics, Inc. filed an 8-K on January 19, 2024, reporting an event that occurred on January 15, 2024. This filing indicates a change in leadership

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX